Loading company…
RheaVita develops freeze-drying equipment and technology for biopharmaceutical applications.
Founded in 2018 and based in Belgium, RheaVita develops lyophilisation technology for the biopharmaceutical sector. Its RheaLyo platform includes a research and development freeze-dryer and GMP-compliant systems for continuous freeze-drying. In June 2021, it raised EUR 2.5 million in Series A funding co-led by Novalis Biotech and PMV - ParticipatieMaatschappij Vlaanderen NV.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in